On 9 May 2025, the US International Trade Commission (ITC) published a notice announcing the closure of its investigation into wearable electronic devices with electrocardiogram (ECG) functionality. The ITC determined to dismiss the complaint as moot, following a 7 March 2025 ruling by the US Court of Appeals for the Federal Circuit, which affirmed the unpatentability of all asserted patent claims. In response, the ITC instituted and subsequently terminated a rescission proceeding, and formally rescinded the limited exclusion order and cease and desist order previously issued against Apple Inc. The ITC’s actions followed the Federal Circuit’s mandate issued on 28 April 2025.
Original source